Introduction
Neurodegenerative diseases are marked by neuronal cell death and loss [1] . In Alzheimer's disease (AD), the selective loss of neurons, particularly in the hippocampus and frontal cortical associative areas, is a feature of the disease [2] . Although a unifying model for neurodegeneration in AD is incomplete, abnormal accumulation of ␤ -amyloid and tau represent leading pathogenic mechanisms [3] . In addition, novel paradigms for cell death in AD, ranging from mitochondrial dysfunction to metal toxicity, may also contribute to the development and progression of AD [4, 5] . One current hypothesis for AD pathogenesis postulates that neuronal death is causally linked to aberrant cell-cycle reentry, through a process termed 'cycle-related neuronal death' (CRND) [6] . Evidence for CRND includes the observation that some neurons in AD brains are immunoreactive for cell cycle proteins such as PCNA [7, 8] , and Ki67 [9] , as well as several cyclins [10] [11] [12] and cyclin-dependent kinases (CDKs) [13, 14] .
An important consequence of the proposed cell cycle re-entry is the existence of tetraploid neurons, which has also been inferred through the observation of tetrasomic nuclei in AD brains without the benefit of neuronal markers [15] . Tetrasomy refers to a chromosomal duplication, usually of a single chromosome pair, contrasting with tetraploidy, which refers to a complete duplication of all chromosomes (2N), resulting in a 4N karyotype. When identified using single chromosome pair fluorescence in situ hybridization (FISH), four signals would be identified for both a tetrasomic and tetraploid cell, yet total DNA content would differ vastly between these two states. This distinction is important in view of the presence of aneuploid cells in the normal brain [16, 17] , raising the possibility that the inferred tetraploid neurons may actually be tetrasomic. In addition, the neuronal identity of such cells remains unclear. Two corollaries stemming from CRND are that: (1) truly tetraploid neurons must exist in the AD brain, and (2) they should be strikingly more prevalent than in control brains that do not have the same degree of neuronal death. Here we have addressed these corollaries by combining DNA fluorescence-activated cell sorting (FACS), FISH and neuronal immunolabeling on nuclei from human AD brains.
Materials and Methods

Tissue Processing
All human protocols were approved by the Human Subjects Committee at The Scripps Research Institute and conform to National Institutes of Health guidelines and public law. Brain tissue was obtained from the University of Maryland Brain and Tissue Bank (National Institute of Child Health and Human Development NO1-HD-8-3284) and stored at -80 ° C until use. For this study, we isolated nuclei from 7 (4 cortical and 3 hippocampal) AD and 7 control patients (mean age = 66.3 years old for control and 80.0 for AD). Cortical samples were obtained from the frontal cortex (Broadman's areas 9, 10 and 11), while CA1, CA3 and dentate gyrus fields were present in sagittal sections of the hippocampal samples. AD brain samples were pathologist verified and had Braak scores of V or VI, and control samples had Braak scores of II or less. Samples were thawed at -20 ° C prior to incubation in Ca 2+ /Mg 2+ -free PBS (CMF-PBS) supplemented with 2 m M EGTA for 60 min on ice. Following this, samples were gently triturated using a series of filtered pipet tips with decreasing bore diameter and filtered through 40-m nylon mesh (BD Biosciences, Bedford, Mass., USA). After centrifugation at 500 g for 5 min at 4 ° C, nuclei were isolated from the cell pellet as described previously, and fixed for 10 min with ice-cold 1% paraformaldehyde at 4 ° C. After removal of the fixative, the isolated nuclei were washed twice in CMF-PBS and stored overnight in CMF-PBS with propidium iodide (50 g/ml). Prior to FACS, nuclei were treated with 50 g/ml RNAse A for 20 min at 37 ° C.
FISH Probes
FISH centromere enumeration probes (CEP) against the centromeric sequence of chromosomes 4 or 6 were obtained from Abbott Molecular (Des Plaines, Ill., USA). Locus-specific FISH probes for chromosomes 4, 6, and 21 were generated by nick translation. Briefly, BAC clones containing DNA sequences for human chromosome 4 (RP11-11P12, RP11-7G22, and RP11-185B5), chromosome 6 (RP11-24F12, RP11-91C23), and chromosome 21 (RP11-30D19, RP11-50N20, RP11-48C23, RP11-66H5, CTC-82515) were grown in LB medium supplemented with 12.5 g/ml chloramphenicol (Sigma Aldrich) overnight at 37 ° C. BAC DNA was isolated using NucleoBond BAC kits (Clontech, Mountain View, Calif., USA). Amino-allyl dUTP (Sigma Aldrich) was incorporated into template DNA using standard nick translation, to which Alexa Flour 488 was then covalently attached. After labeling and purification using QuiaPrep PCR Purification Kits (Qiagen, Valencia, Calif., USA), a 20-fold excess of human Cot-1 DNA (Invitrogen, Carlsbad, Calif., USA) was added prior to ethanol precipitation. The purified, labeled DNA probe was resuspended in hybridization buffer (2 ! SSC/50% formamide/10% low-molecular-weight dextran sulfate), and stored at -20 ° C until use. The high-sequence homology of the chromosome 21 and chromosome 13 centromeres necessitated generation of two locus-specific FISH probes for the q-arm of chromosome 21 (image not shown).
FACS and Immunostaining
Isolated nuclei were sorted using a FACS Aria (Becton Dickinson) flow cytometer after machine calibration with chick erythrocyte nuclei (CEN) (Biosure, Grass Valley, Calif., USA). Unsorted, fraction N (typically composed of 90-95% of all nuclei) and fraction C (typically composed of 5-10% of all nuclei) were sorted into CMF-PBS and then dropped onto precleaned glass slides to allow the liquid to evaporate. Slides were blocked overnight in 2.5% BSA/1% Triton-X 100 PBS at pH 7.4. The primary antibodies NeuN (used at 1: 100 dilution; Chemicon, Temecula, Calif., USA) and HuC/D (used at 10 g/ml; Invitrogen) were detected with an Alexa Fluor 488-labeled donkey anti-mouse secondary antibody (used at 1: 500 dilution; Invitrogen).
Fluorescence in situ Hybridization
After sorting and immunostaining, slides were immersed in 2 ! SSC for 10 min at room temperature. The slides were dehydrated through ethanol, denatured at 75 ° C for 2 min in denaturation solution (2 ! SSC/70% formamide), and passed through an ice-cold ethanol dehydration series. DNA probes were denatured at 80 ° C for 7 min and allowed to reanneal for 60 min before hybridization. After overnight hybridization at 37 ° C, slides were rinsed in 4 ! SSC to remove the coverslips, and passed through 2 ! SSC/50% formamide pH 7.0 for 5 min, 4 ! SSC 0.1% (v/v) Tween-20 for 2 min, and 2 ! SSC for 2 min. After counterstaining with DAPI, slides were dehydrated through ethanol and coverslipped with Vectashield antifade solution (Vector Labs, Burlingame, Calif., USA). Slides were stored at -20 ° C until analysis. For sequential hybridizations, a series of FISH images was acquired using an Olympus IX70 microscope equipped with an automated stage (Applied Precision, Issaquah, Wash., USA), capable of marking the nuclear position on the slide. After removing the first probe set by immersion in 2 ! SSC/70% formamide pH 7.0 for 2 min at 60 ° C, the next probe set was applied and FISH images were acquired from the same nuclei. This process was repeated for the third hybridization. For experiments where neuronal immunolabeling was followed by chromosome-specific FISH, a minimum of 500 neuronal (NeuN or HuC/D positive) fraction C nuclei per sample were scored for FISH signals. 
Results
Isolation and Characterization of Nuclei from Postmortem Human Brain Samples
To test the possibility that tetraploid neurons exist in the adult brain and are more prevalent in the AD brain, nuclei from pathologist-verified and sex-matched sporadic AD and nondemented control frontal cortices and hippocampi were isolated, blind to their identity, then sorted based on DNA content to identify tetraploid cells. Nuclei prepared with an optimized propidium iodide staining protocol (including RNAse pretreatment) were sorted by FACS to isolate two pools of nuclei: putative nonmitotic nuclei (fraction 'N') with near-diploid DNA contents, and putative S-phase cycling nuclei (fraction 'C') with greater-than-diploid DNA contents ( fig. 1 a, b ; N vs. C). To provide a very conservative assessment of potentially tetraploid neurons, fraction C included both the traditional 4N peak as well as populations flanking the 4N peak (including the region of the 2N peak exhibiting the greatest fluorescence), to account for hypothetical technical artifacts that may have missed 4N neurons. Fraction C nuclei were then dropped onto glass slides for further analysis by immunolabeling and FISH. We detected neurons by immunolabeling for the neuronal antigens NeuN ( fig. 1 c) and HuC/D ( fig. 1 d) , which comprised between 17 and 48% of fraction C nuclei, depending on the sample ( fig. 1 e) . Despite variations in neuronal number between individual brain samples, the percentages of neurons within each sample were similar for 2 ) . A truly tetraploid neuron must be present in fraction C, based upon its DNA content. In order to test this possibility, we generated FISH probes for three selected autosomes, chromosomes 4, 6 and 21. For chromosomes 4 and 6, we generated a locus-specific qarm FISH probe for use in conjunction with a commercially available centromeric probe ( fig. 3 a, b) . The probe set for chromosome 21 consisted of two locus-specific qarm probes (data not shown). FISH probes were validated for binding specificity by hybridization to interphase and metaphase human lymphocytes ( fig. 3 a, b) . Additional verification of probe specificity was performed by hybridization of locus/centromeric probes in combination with the corresponding whole chromosome paint (data not shown) [16] . FISH analyses of chromosomal copy number in fraction C revealed many nuclei with four signals in all samples analyzed ( fig. 3 c) . Although the percentages of tetrasomic nuclei varied between samples, we did not detect an increase or decrease in the percentage of tetrasomic nuclei in AD brain samples compared to controls for either the frontal cortex or hippocampus ( fig. 4 ) . Remarkably, up to 35% of fraction C nuclei were tetrasomic (4-35% range); however, because fraction C comprised around 10% of all brain nuclei (propidium iodide positive and ungated), the overall level of tetrasomy in the brain based on these data would range between 0.4 and 3.5%, consistent with previous reports [16, 17] . In order to determine if these nuclei were truly tetraploid (rather than tetrasomic for the chromosomes assayed), we sorted fraction C nuclei by FACS and then sequentially hybridized the same nuclei with probes for these three different chromosomes. We applied a first set (chromosome 4 telomeric and centromeric) of FISH probes to the target nuclei and used deconvolution microscopy to obtain images of tetrasomic nuclei. We next marked their position on the slide, stripped off the first set of probes and applied the second set (chromosome 6), using their marked locations to return to the same nucleus for imaging. The process was repeated for the third set (chromosome 21). In every instance, we found tetrasomic signals for all chromosomes analyzed, in both control and AD brain samples. These data demonstrated that fraction C nuclei were likely tetraploid, based on their DNA content and assayed FISH signals ( fig. 3 d) . By comparison, fraction N contained the expected prevalence of eusomic and aneusomic neurons and nonneuronal cells observed in prior reports [16, 17] along with an absence of tetraploid cells (data not shown).
We next asked if tetraploid nuclei had a stereotyped distribution in the nondiseased brain as compared to AD. To determine the neuroanatomical position of these apparent tetraploid nuclei in the brain, we performed FISH in tissue sections, where the detection of tetraploid cells is less likely to be limited by a tissue-sectioning artifact. In the nondiseased cortex, we found tetrasomic nuclei in all cortical layers (1-5/6) as well as in white matter tracts below the ventricular surface . Tetrasomic nuclei showed a similar random pattern of distribution in the nondiseased hippocampus. However, the prevalence and distribution of these cells were indistinguishable between control and AD samples in cortical and hippocampal areas ( fig. 3 e) .
The intense red/green fluorescence along the nuclear periphery ( fig. 3 e) comes from lipofuscin, a broadly autofluorescent metabolic byproduct that accumulates with age in neurons and glial cells of the human brain [18, 19] .
Sequential Immunolabeling and FISH of Tetraploid Nuclei from Postmortem Human Brain Samples
The finding that neurons and tetraploid cells were present in fraction C prompted us to address whether there was some overlap between these two populations. The possible neuronal identity of tetraploid nuclei was assessed by immunolabeling for the neuron-specific nuclear markers NeuN and HuC/D, combined with FISH to produce nuclei double-labeled for neuronal and chromosomal markers [20, 21] . After sorting fraction C nuclei, we performed NeuN or HuC/D immunolabeling as described previously, marking the location of neuronal nuclei using a microscope equipped with an automated stage. These samples were then processed for FISH analysis to identify any tetraploid neurons. Using this ap- proach, we were able to double label fraction C nuclei for a neuronal marker and a chromosome probe. After identity-blind analyses of over 3,500 NeuN or HuC/D immunolabeled nuclei from 14 individuals (control and AD), no tetraploid neuronal nuclei were identified in the cerebral cortex or hippocampus. This result contrasted with hundreds of nonneuronal (NeuN or HuC/D negative) nuclei showing 4 FISH signals in all brain samples analyzed ( fig. 5 ) . Thus, despite the high prevalence of tetraploid nuclei in the AD brain, none were demonstrably tetraploid neurons.
Discussion
CRND predicts that the AD brain should have vastly more tetraploid neurons. Our data are incompatible with this prediction. All tetraploid nuclei observed, assessed by not only FISH but DNA content FACS and neuronal marker immunolabeling, were nonneuronal along with being indistinguishable with respect to prevalence and distribution between control and AD brains. The absence of tetraploid neurons in fraction C is unlikely to be explained by antigen loss associated with cell death, as NeuN remains detectable even in apoptotic cells [22] , while complementary results were obtained using the distinct neuronal antigen, HuC/D. Virtually all neurons in the cortex and hippocampus reportedly express NeuN [21] ; however, it is formally possible that some proportion of tetraploid nuclei may be neuronal without expressing this antigen. Nevertheless, even if this unlikely scenario were to exist, our data indicate that such hypothetical tetraploid neurons would not occur specifically in AD.
These data do not address the role of cell cycle proteins reported in postmitotic neurons [reviewed in 6 ], although the data do not support their canonical cell cycle function in CRND. This begs the question of what roles cell cycle proteins play in postmitotic neurons. Novel functions for PCNA, cyclins and CDKs have been described beyond their roles in cell cycle progression, notably in DNA damage responses [23] [24] [25] [26] . Given the extent of DNA damage incurred by aging and degenerating neurons in AD, it seems likely that the observed re-expression of many cell cycle proteins in this setting may reflect a DNA repair and maintenance response of vulnerable neurons [27] [28] [29] , or perhaps other as yet unidentified functions distinct from CRND. AD is a slowly progressing disease, often taking decades to manifest in humans. Estimates regarding the rate of neuronal clearance in AD vary [2, 30] , and it is conceivable that our analysis failed to detect tetraploidy in neurons because of their rarity. Recent studies using BrdU injections and NeuN FACS have estimated that the maximum number of adult generated neocortical neurons is ! 0.07% of all neocortical cells [31, 32] . These studies did not actually detect any tetraploid neurons, but arrived at this maximum rate by assuming that a theoretical 'next cell' in their analysis was a true positive, and then calculating the maximum rate of observable events. A similar analytical treatment of data can be used to determine a detection limit for tetraploid neurons in our study. As a representative example, FACS-sorted fraction C nuclei from the AD hippocampus made up around 5% of the total input nuclei (all propidium iodide-positive non-CEN events). NeuN immunolabeling of fraction C AD hippocampal nuclei revealed that 35% of this population was neuronal ( fig. 2 ) . For each sample, we counted a minimum of 500 fraction C neurons [500/0.35 = 1,428 fraction C nuclei (neuronal and nonneuronal) which is 5% of the total number of unsorted nuclei or 1,428/.05 = 28,560 total nuclei]. If the next nucleus analyzed represented a hypothetical tetraploid neuron in fraction C, then this would also represent a maximum observable rate of neuronal tetraploidy at any given time of 1 in 28,571, or 0.003% of all nuclei. A calculation for the AD cortex reveals a similarly low hypothetical maximum rate of neuronal tetraploidy of 0.003%. Therefore, while it remains formally possible that tetraploid neurons were missed in our analysis, these cells would be (1) exceedingly rare and (2) a priori equally probable in both AD and control cases, rendering this possibility nonspecific for AD. There remains a formal possibility that the rate of cell death through a neuronal tetraploid intermediate could be increased early in the disease and cleared by apoptotic/necrotic mechanisms. Our approach of using samples between 63 and 88 years of age might miss these events, although it is notable that this situation is common to many if not most studies using typical AD brain samples. Moreover, it would indicate that even a 25-year time span for our sporadic AD samples is insufficient to capture any of the postulated tetrapolid neurons.
Alternative functions for cell cycle proteins are further suggested by the singular expression of either cyclins or CDKs in the adult AD brain, which may not be sufficient for cell-cycle re-entry since the expression of a cyclin/ CDK complex is required for biological activity [33] . Recent studies have suggested that in rodent models of injury-induced neuronal apoptosis and human presenile dementia, DNA synthesis as detected by BrdU incorporation occurs predominately in microglial and endothelial cells, but not in neurons [34, 35] . Combined with data presented here, it appears that nonneuronal cells and/or tetrasomic rather than tetraploid neurons could account for prior data supporting CRND. New therapies to treat AD based upon CRND may be potentially viable [36, 37] ; however, their mechanisms of action would most likely involve nonneuronal cells.
